Modeling Patient-Derived Glioblastoma with Cerebral Organoids by Linkous, Amanda, Balamatsias, Demosthenes, Snuderl, Matija, Edwards, Lincoln, Miyaguchi, Ken, Milner, Teresa, Reich, Batsheva, Cohen-Gould, Leona, Storaska, Andrew, Nakayama, Yasumi, Schenkein, Emily, Singhania, Richa, Cirigliano, Stefano, Magdeldin, Tarig, Lin, Ying, Nanjangud, Gouri, Chadalavada, Kalyani, Pisapia, David, Liston, Conor, Fine, Howard A.

Get full text

Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade by Arora, Vivek K., Schenkein, Emily, Murali, Rajmohan, Subudhi, Sumit K., Wongvipat, John, Balbas, Minna D., Shah, Neel, Cai, Ling, Efstathiou, Eleni, Logothetis, Chris, Zheng, Deyou, Sawyers, Charles L.

Get full text

Abstract 4172: Activation of AR signaling by mifepristone enhances prostate cancer growth and impairs enzalutamide response by Zhou, Haiying, Jachan, Nadine, Singh, Mallika, Tran, Chris, McWeeney, Dan, Balbas, Minna, Schenkein, Emily, Zovorotinskaya, Tatiana, Jackson, Erica L., Medina, Julio, Sun, Daqing, Rew, Yosup, Du, Xiaohui, Eksterowicz, John, Yan, Xuelei, Zhu, Liusheng, Ye, Qiuping, Fantin, Valeria

Get full text

Glucocorticoid Receptor Confers Resistance to Anti-Androgens by Bypassing Androgen Receptor Blockade by Arora, Vivek K., Schenkein, Emily, Murali, Rajmohan, Subudhi, Sumit K., Wongvipat, John, Balbas, Minna D., Shah, Neel, Cai, Ling, Efstathiou, Eleni, Logothetis, Chris, Zheng, Deyou, Sawyers, Charles L.

Get full text

Phase I Dose Escalating Trial of Bortezomib (Velcade®) in Combination with Idarubicin and Cytarabine in Patients with Acute Myeloid Leukemia by Attar, Eyal C., DeAngelo, Daniel J., Ballen, Karen K., Learner, Emily, Trehu, Elizabeth G., Schenkein, David P., Levine, James D., Stone, Richard M., Amrein, Philip C.

Get full text